Загрузка...
Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
BACKGROUND: For patients with MS, medication switches increase the risk of disease reactivation. OBJECTIVE: Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. METHODS:...
Сохранить в:
| Опубликовано в: : | Mult Scler J Exp Transl Clin |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8209840/ https://ncbi.nlm.nih.gov/pubmed/34188949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20552173211022027 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|